Athersys: MultiStem cell therapy granted RMAT designation from FDA

Athersys announced that MultiStem cell therapy was granted Regenerative Medicine Advanced Therapy designation from the U.S. FDA for the acute respiratory distress syndrome program. The RMAT designation enables sponsors to [...]